A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas
Clinical trial NCT03220347 · TERMINATED
Trial details
- NCT number
- NCT03220347
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2024-09-06
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.